newsfilter
← Latest News
GlobeNewswire·

Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates

Important progress across four clinical-stage programs demonstrating depth and breadth of obesity pipeline Initiated five late-stage global clinical trials in obesity, including the ribupatide injection KaiNETIC Phase 3